MicroRNAs (miRNAs) are small, non-coding RNAs found throughout the eukaryotes that control the expression of a number of genes involved in commitment and differentiation of hematopoietic stem cells and tumorigenesis. Widespread dysregulation of miRNAs have been found in hematological malignancies, including human acute myeloid leukemia (AML). A comprehensive understanding of the role of miRNAs within the complex regulatory networks that are disrupted in malignant AML cells is a prerequisite for the development of therapeutic strategies employing miRNA modulators. Herein, we review the roles of emerging miRNAs and the miRNAs regulatory networks in AML pathogenesis, prognosis, and miRNA-directed therapies.
CITATION STYLE
Liao, Q., Wang, B., Li, X., & Jiang, G. (2017). miRNAs in acute myeloid leukemia. Oncotarget. Impact Journals LLC. https://doi.org/10.18632/oncotarget.12343
Mendeley helps you to discover research relevant for your work.